• Direct Antiviral Therapy of Hep C May Not Boost Hepatocellular-Carcinoma Risk

    4 monthes ago - By Medscape

    Treatment of hepatitis C with direct-acting antiviral agents does not appear to increase the risk of hepatocellular carcinoma in individuals with cirrhosis, researchers from France report.
    Reuters Health Information
    Read more ...